EMEA-002860-PIP01-20 - paediatric investigation plan

Ramipril

Bisoprolol fumarate

Key facts

• Active Substance:
  • Ramipril
  • Bisoprolol fumarate
• Therapeutic area:
  Cardiovascular diseases
• Decision number:
  P/0497/2020
• PIP number:
  EMEA-002860-PIP01-20
• Pharmaceutical form(s):
  Capsule, hard
• Condition(s) / indication(s):
  Treatment of hypertension
• Route(s) of administration:
  Oral use
• Decision type:
  W: decision granting a waiver in all age groups for all conditions or indications
• Decision date:
  22/12/2020

Decision

P/0497/2020 : EMA decision of 22 December 2020 on the granting of a product specific waiver for ramipril / bisoprolol (fumarate) (EMEA-002860-PIP01- 20)

AdoptedReference Number: EMA/628688/2020